Results 1,941-1,960 of 12,424 for speaker:Louise O'Reilly

Written Answers — Department of Health: Medical Products (7 Nov 2017)

Louise O'Reilly: 848. To ask the Minister for Health if he will request the HSE and private surgeons that have implanted transvaginal mesh devices to write to the women involved outlining the possible complications or side effects which are associated with such implants in order that their attention is drawn to issues and they are informed in this regard, in view of the fact that many side effects do not...

Written Answers — Department of Health: General Practitioner Training (7 Nov 2017)

Louise O'Reilly: 850. To ask the Minister for Health if general practitioners will received additional training to identify mesh related complications; and if he will make a statement on the matter. [46981/17]

Written Answers — Department of Health: Health Services Provision (7 Nov 2017)

Louise O'Reilly: 858. To ask the Minister for Health if vertebral body tethering for the treatment of scoliosis is available via the HSE; and if he will make a statement on the matter. [47016/17]

Written Answers — Department of Health: Health Services Provision (7 Nov 2017)

Louise O'Reilly: 859. To ask the Minister for Health if his attention has been drawn to persons who have accessed vertebral body tethering via the cross-border health directive; the dates for this treatment; the name of the physician recommending it here; and the follow-up care provided by the HSE. [47017/17]

Written Answers — Department of Health: Organ Donation (7 Nov 2017)

Louise O'Reilly: 860. To ask the Minister for Health if his attention has been drawn to the specific charges by HSE and voluntary public hospitals for bone marrow donors; if his attention has been further drawn to the practice of charging donors for their stay in hospital; and if he will make a statement on the matter. [47018/17]

Written Answers — Department of Health: Organ Donation (7 Nov 2017)

Louise O'Reilly: 861. To ask the Minister for Health if a reimbursement scheme is in place for bone marrow donors for the recoupment of expenses such as charges for overnights in hospital, transport to and from hospital, car parking and so on; and if he will make a statement on the matter. [47019/17]

Written Answers — Department of Health: Hospital Procedures (8 Nov 2017)

Louise O'Reilly: 155. To ask the Minister for Health when transvaginal mesh (details supplied) was first used by the HSE; and if he will make a statement on the matter. [47236/17]

Written Answers — Department of Health: Emergency Departments (8 Nov 2017)

Louise O'Reilly: 158. To ask the Minister for Health the status of a request by Letterkenny University Hospital to reopen its short-stay ward and 20 beds to alleviate the pressure on the accident and emergency department at the hospital; if the hospital's related request for additional staff to operate the ward will be addressed; and if he will make a statement on the matter. [47249/17]

Joint Oireachtas Committee on the Eighth Amendment of the Constitution: Business of Joint Committee (8 Nov 2017)

Louise O'Reilly: Agreed.

Joint Oireachtas Committee on the Eighth Amendment of the Constitution: International Legal and Services Context: Dr. Gilda Sedgh, Guttmacher Institute and Ms Leah Hoctor, Center for Reproductive Rights (8 Nov 2017)

Louise O'Reilly: I will not need the full six minutes as my question is a very simple one. It concerns the word "risk". We know from the Citizens' Assembly what it is that we are asked to consider here. The assembly has a gradation of risk or "serious risk" to use its own term. There are various definitions of what does or does not constitute risk. In Dr. Sedgh's experience, is it possible or even...

Joint Oireachtas Committee on the Eighth Amendment of the Constitution: International Legal and Services Context: Dr. Gilda Sedgh, Guttmacher Institute and Ms Leah Hoctor, Center for Reproductive Rights (8 Nov 2017)

Louise O'Reilly: Yes. My apologies. I should have been clearer.

Joint Oireachtas Committee on the Eighth Amendment of the Constitution: Risks to Mental Health: Dr. Anthony McCarthy, National Maternity Hospital, Holles Street (8 Nov 2017)

Louise O'Reilly: That is fine. To return to one of the points made by Senator Ruane, I do think there has to be a certain amount of respect given to those of us on the committee when we are discussing pregnancy related issues who have had that very personal experience. I found the content of some of what was said quite disrespectful. I do not intend to get into a row with anybody about it. In fact, the...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: I thank the witnesses for their evidence. I have a number of questions and I would imagine that none will shock or surprise the witnesses. Following our engagement with Alpha One Foundation, specifically in respect of Respreeza, I have stated publicly that the families of the patients involved have been treated disgracefully. I would apportion blame equally to all involved in this. The...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: To follow on from a point made by Deputy Kelleher, the rare diseases plan runs from 2014 to 2018 so we are very far into it. It strikes me that very little has been done. Will the witnesses give an indication as to whether they feel all of this work will be completed by the end of the plan? That is what people want to know. The witnesses might give us an idea of what will not be achieved...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: All members have done some research on the issue. Is it correct that there are young children on the drug in the countries the witness listed where conditional access has been granted?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: Let us take Britain as an example. In England and Northern Ireland the drug is being reimbursed. Is that being done on a conditional basis or otherwise?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: The families of the kids who are waiting to hear about the availability of this drug are very anxious and are watching these proceedings. They do not believe a mistake was made but, rather, a certain amount of compassion was shown. With regard to most of the countries where it is available or the countries the witness listed where it is not available in any form, conditional or otherwise,...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: I suspect Professor Barry is playing with words because I think it is available to people via the public system but we can agree to differ on that.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: As regards the Irish system, the witness knows the families are very anxious to know what will happen. There is a court case in progress and perhaps the witness will address that at a later stage.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: I have something that specifically relates-----